On 1 July 2017, DSC approved the first draft of our strategy aptly named "OvercomingSCD" to guide our work, growth and development over an initial six year course and beyond in a major phase to change the narrative of SCD in Nigeria and the larger Africa and guide our evolution as an organization.
At its core, OvercomingSCD is all about impact – specifically, the impact of DSC’s activities on the health of millions of people living with or affected by SCD(PLWSCD), particularly children, women and those living in disadvantaged circumstances in underserved communities and resource-poor countries alike.
Our people-first model integrates the perspectives of PLWSCD into our solutions, driving innovative and informed approaches to addressing percieved barriers while we strive to establish high-impact interventions and implementations that can be measured and scaled up.
Our multi-sectoral approach will engage with PLWSCD, young leaders, local and international organizations, governments, healthcare providers and civil society organizations and the media through traditional and new social media channels to contribute to addressing perceived barriers to SCD care and prevention.
By 2035, we expect sickle cell disease to be on the global agenda and a central consideration in all national health plans, with increased investment in prevention, early detection, treatment and care all resulting in improved overall health of PLWSCD, decrease in prevalence, streamlined informed data collection and lowering of mortality, particularly in low- and middle-income countries.
Our Strategic Plan
Over the next six years and beyond, OvercomingSCD will guide the development of high-impact interventions, inform new initiatives, activities, policies and resource decisions, as well as re-orient and re-focus our approaches to tackling the challenges of sickle cell disease in Nigeria and Africa.
The OvercomingSCD Strategic Plan positions us to respond to the challenge of SCD as well as embrace new opportunities as they arise. Building on our strenghts and the combined resources and capabilities of partnerships, we set out our ambitious vision of overcoming sickle cell disease in Africa.